Thus, based on our promising in vitro results showing that ZNS normalizes GABAAR expression, we speculated that ZNS would help reduce seizures in Dravet syndrome caused by the GABRG2(Q390X) mutation. The gene discussed is GABRG2; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.